CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C

Press/Media: Press / Media

PeriodOct 4 2018 → Oct 5 2018

Media coverage

6

Media coverage

  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletTMC Net
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD : Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletMarketScreener.com
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletSPi World News
    CountryUnited Kingdom
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletGlobeNewswire
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletBizWire Express
    CountryIndia
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
    Media name/outletGlobal Banking & Finance Review
    CountryUnited Kingdom
    Date10/4/18
    PersonsDarius Adams